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The relatively uncommon fungal pathogen Cryptococcus gattii recently emerged as a signiﬁcant cause of cryptococcal disease in
human and animals in the Paciﬁc Northwest of North America. Although genetic studies indicated its possible presence in the
Paciﬁc Northwest for more than 30 years, C. gattii as an etiological agent was largely unknown in this region prior to 1999.
The recent emergence may have been encouraged by changing conditions of climate or land use and/or host susceptibility, and
predictiveecologicalnichemodelingindicatesapotentiallywiderspread.C.gattiicansurvivewideclimaticvariationsandcolonize
theenvironmentintropical,subtropical,temperate,anddryclimates.Long-termclimatechanges,suchasthesigniﬁcantlyelevated
global temperature in the last 100 years, inﬂuence patterns of disease among plants and animals and create niche microclimates
habitablebyemergingpathogens.C.gattiimayhaveexploitedsuchahithertounrecognizedbutclementenvironmentinthePaciﬁc
Northwest to provide a wider exposure and risk of infection to human and animal populations.
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1.Introduction:The Organismandthe Disease
Cryptococcus gattii (formerly, Cryptococcus neoformans var.
gattii)[ 1] is a basidiomycetous yeast pathogenic to immuno-
competent mammals including humans. This relatively
uncommon organism diﬀers from the congeneric, more
commonly encountered pathogen, C. neoformans,w i t h
regards to phenotypic characteristics, natural habitat, epi-
demiology, ecology, clinical manifestations of disease, and
responses to antifungal therapy [2]. Phylogenetic studies
have shown that C. gattii and C. neoformans diverged
from a common ancestor approximately 40 million years
ago [3]. Hosts acquire cryptococci via inhalation, and
the disease (“Cryptococcosis”) caused by both C. gattii
and C. neoformans aﬀects the lungs, with the potential to
disseminate to distant tissues, most frequently, the central
nervous system, causing life-threatening meningoencephali-
tis [4]. Compared to C. neoformans, C. gattii infections more
often cause granulomatous lesions (cryptococcomas) in lung
and brain, with more associated neurological sequelae and
morbidity [5–8]. Though otherwise healthy hosts presenting
with meningitis respond to antifungal therapy, complete
mycological cure (culture negativity) appears to be more
often delayed [7, 9]. Genetic typing studies using molecular
techniques have identiﬁed distinct haploid genotypes among
the clinical, veterinary, and environmental isolates of C.
gattii, namely, VGI, VGII (further subdivided into VGIIa,
VGIIb [10, 11], and recently VGIIc [12]), VGIII, and VGIV
[11–15]. The genotype VGIIa was preponderantly present
in the emergence of C. gattii disease in 1999 on Vancouver
Island and Lower Mainland of British Columbia (BC) in
Canada, and has, therefore, been termed the “Vancouver
Island major emergence strain”; it was found to be unique
to the Paciﬁc Northwest and hypervirulent in mouse studies
[10, 11].
2.C. gattii Outbreakin the Paciﬁc Northwest
C. gattii emerged as an agent of life-threatening infections in
the Paciﬁc Northwest of North America in 1999. Previously
unknown in the region, more than 200 cases of C. gattii
have now been documented in humans, and more than twice
that number in domestic animals, accounting for an average
annual incidence of 6.5 cases per million in BC or 27.92 Interdisciplinary Perspectives on Infectious Diseases
cases per million on Vancouver Island; this is the highest
“endemic” incidence reported worldwide [16]. There has
been a substantial mortality from this disease; between 1999
and 2006, the case fatality rate from C. gattii disease was
e s t i m a t e dt ob e4 . 5 %[ 17].
Although the majority of locally acquired C. gattii cases
occurred in Vancouver Island residents, since 2004 there has
been a steady increase in the numbers among BC Lower
Mainland residents [17]a sw e l la sa m o n gt h eN o r t h w e s t e r n
states in the United States (Washington and Oregon) [10, 11,
16, 18–20]. To date, we are aware of approximately 20 cases
of C. gattii disease diagnosed in humans in Washington and
Oregon, many of whom have had no travel history to any
known C. gattii-disease endemic zone (K Marr, unpublished
observation). The organism has also been recovered from
theenvironmentinWashingtonState[16].Anoverwhelming
majorityoftheseisolatesbelongedtothemoleculargenotype
VGII (∼95% VGIIa; ∼5% VGIIb) and one VGIII [10–12, 14,
16, 19, 20]. Though the exact mode of transport of C. gattii
from Vancouver Island to the Lower Mainland is not known,
studies of possible dispersal mechanisms have indicated
association of C. gattii cases with high-traﬃc locations, and
evidence of human-associated dispersal through wheel wells
ofcars,shoes,andmovementofsoilorwoodproductsaswell
as water [18, 21].
Since 1999, the incidence of C. gattii infection in domes-
tic animals has increased greatly in Western North America,
in parallel with the outbreak of human cryptococcosis.
C. gattii disease has been diagnosed in dogs, cats, ferrets,
porpoises, alpacas and llamas, horses, and psittacine birds
on Vancouver Island, BC Lower Mainland [22–24]a sw e l l
as in Washington and Oregon [12, 16, 20]. Cryptococcal
infection in animals occurs from inhalation of airborne
infectious propagules (yeast or spores) and subsequent
colonization of the nasal cavity and paranasal sinuses,
often resulting in asymptomatic carriage and/or subclinical
infection [2, 22]. Subclinically infected animals may clear
the organism, remain protractedly colonized and/or infected
(with repeatedly positive serum for cryptococcal antigen), or
progress to clinical disease [25]. Disease can be manifested
by upper respiratory symptoms, subcutaneous nodules,
pneumonia, central nervous system and/or ocular disorders,
andlymphadenopathy[2,24].AuniquefeatureofthePaciﬁc
Northwest outbreak is the number of marine mammals, pri-
marily porpoises, which have died with C. gattii pneumonia
[24]. Over 90% of the veterinary isolates have belonged to
molecular type VGIIa [16, 22–24]. Identiﬁed risk factors in
animals in this region include disturbance of soil and/or
human activities such as logging within 10km, hiking, or
hunting in areas colonized with C. gattii [26].
3.C. gattii: Establishment inaNovel
EnvironmentalNiche
In a seminal study on the epidemiology ofcryptococcosis
[27], it was noted that the majority of clinical cases of
C. gattii disease occurred in people residing in hot and
humid climates of the tropics and subtropics. Prior to
1999, the geographical regions with any degree of C. gattii
endemicity included Australia and New Zealand, Papua New
Guinea, South and Southeast Asia (Cambodia, Malaysia,
Thailand, Vietnam, China, Taiwan, Singapore, Nepal, and
the Indian subcontinent), parts of Latin America (Argentina,
Brazil, Colombia, Uruguay, Paraguay, Peru, and Venezuela),
Southern California, Mexico, Hawaii, Central and South
Africa, and certain parts of Europe (Austria, Germany,
France, Italy, Greece, and Spain) (reviewed in [2]; also see
[28–32]).
Studies from Australia and elsewhere [2] indicate that
C. gattii can colonize the environment in tropical, sub-
tropical, temperate, and dry climates. Although C. gattii
grows slower at 37◦Cc o m p a r e dt oC. neoformans isolates
[33], environmental isolates of C. gattii grow equally well
at 30◦Ca n d3 7 ◦C—a survival property believed to be
mediated in part by a manganese-containing mitochondrial
superoxide dismutase (SOD2) which is induced at elevated
temperatures [34]. Recent work with environmental isolates
from Vancouver Island has shown that the organism, when
grown in nutritionally deﬁcient soil extract broth, uses
constituents in the soil to produce melanin; these melanized
cells are more resistant to UV irradiation exposure than the
same strains which did not melanize when grown in 1/16th
strength malt extract. The ability of this C. gattii genotype to
resist UV irradiation and colonize with high concentrations
indesiccatedsoilmaycontributetothesurvivalanddispersal
of this strain in this environment [35].
The origins of the C. gattii strains, which now per-
manently colonize the environment on Vancouver Island,
remain unknown. The provincial medical mycology collec-
tion has been examined, and no archived C. gattii isolates
were identiﬁed prior to 1999. Signiﬁcant global dispersal of
cryptococcal strains [14, 36] makes accurate determination
of speciﬁc origin diﬃcult. However, genotypic analysis
enabled the study of lineages of the C. gattii isolates, tracing
the origin and evolution of the organism and establishing its
relevance in the context of the outbreak. All C. gattii clinical
isolates from the Vancouver Island emergence were found to
contain α allele of the mating type-speciﬁc genes (MATα)
and were sexually fertile [11, 37]. Genotypic analysis further
revealed that a rare, nonclassical, same-sex reproduction
between two MATα parents resulted in the VGIIa strain.
These observations support the hypothesis that cryptic
same-sex reproduction may have enhanced the virulence of
the VGIIa genotype, helping a “hypervirulent” strain adapt
to and propagate in the local environmental niche [10]. In
contrast, study of Australian C. gattii populations recovered
from Eucalyptus tree hollows found that the organism exists
aseitherα-mating-typeisolates,orbothaandα-mating-type
isolates, and both unisexual and heterosexual recombination
p r o d u c ei n f e c t i o u ss p o r e s[ 38].
B e c a u s eo fg l o b a ld i s p e r s a l[ 14, 36], it is possible that the
VancouverIslandmajorgenotypeVGIIamayexistelsewhere,
but that remains to be established; one South American
isolate thus far reported to be highly similar to VGIIa diﬀers
at one locus by multilocus sequence typing (MLST). It may
well be related to the major outbreak strain, but either with
ad i ﬀerent origin (in Australia, South America, or within theInterdisciplinary Perspectives on Infectious Diseases 3
PaciﬁcNorthwest),orbygeneticdrift(intransittothePaciﬁc
Northwest, perhaps by mating with another VGII strain).
On the other hand, the minor genotype VGIIb appears to
be identical with fertile isolates from Australia and likely
originated there [10].
In the ﬁrst two Oregon cases of nontravel-associated C.
gattii disease, C. gattii isolates genotyped as VGII, but they
were genetically distinct from either VGIIa or VGIIb strains
f o u n do nV a n c o u v e rI s l a n d[ 16] and the relationship of these
cases to the outbreak is unknown. However, two archived C.
gattii isolates from the United States, NIH444 (a.k.a. ATCC
32609 and CBS6956) and NIH B4534 (a.k.a. CBS7750), were
found to be identical to the Vancouver Island VGIIa strain
[10, 11], leading to the hypothesis that this genotype may
have been present in North America for more than 30 years.
Strain NIH444 was isolated from a sputum sample from
a patient in Seattle, Washington, in the early 1970s, and
strain NIH B4534 was recovered from a Eucalyptus tree in
San Francisco in 1992. It is important to note that we do
not have a complete travel history from the Seattle patient.
However, if this isolate has been in the environment in
Western North America for this long, other factors, such
as changing conditions of climate or land use and/or host
susceptibility, have appeared to encourage its emergence in
more recent years.
4. ClimateChange andDisease Relationship:
Overview
In the last 100 years (1906–2005), the global temperature has
increased by 0.74 [CI, 0.56–0.92]◦C; and the linear warming
trend over the last 50 years (0.13 [CI, 0.10–0.16]◦Cp e r
decade) is nearly twice that for the last 100 years [39]. The
last three decades have seen an unprecedented escalation of
global warming—both at the level of the middle troposphere
and the surface—a large part of it being anthropogenic
throughemissionofgreenhousegases.Long-termchangesin
climate and subsequent eﬀects have been observed at conti-
nental, regional, and ocean basin scales, including changes in
Arctictemperaturesandice,widespreadchangesinhumidity
and precipitation amounts, ocean level and salinity, wind
patterns, and aspects of extreme weather including droughts,
heavy precipitation, heat waves, and the intensity of tropical
cyclones. It has been predicted that the earth in the 21st
century will face some 2◦C( 3 . 5 ◦F) or more in additional
warming[39].However,therateofchangebetweenmicroen-
vironments varies substantially, with polar zones changing
more quickly while other zones remain relatively stable, and
therefore, global averages cannot be used to predict eﬀects of
microclimates. Since 1948, the average annual temperatures
at one site on the eastern coast of Vancouver Island increased
by1.44◦Cwhichisastatisticallysigniﬁcantchange(P<. 001)
(data obtained from Environment Canada). Unfortunately,
many government sponsored meteorological stations have
been abandoned, leaving research scientists with the arduous
task of documenting microclimate variation.
Speculative studies on how a widespread climate change,
speciﬁcally the elevation of global temperature, might aﬀect
the distribution of infectious diseases began about two
decades ago. Health outcomes of climate change are diverse,
a n dd e p e n du p o nm a n yd i ﬀerent factors with respect to
biodiversity, nutrient cycle, physical relocation, internal
defensesystems,andtransmissiondynamicswithinmicrobes
[40]. The initial studies almost exclusively focused on vector-
borne diseases, predicting possible vector movements with
rise in temperature in erstwhile temperate zones. However,
the relationship between climate change and infectious
disease is inherently complex, and not easily amenable to
predictive epidemiology. For example, the impact of climate
change on infectious disease is not restricted to vector-
bornediseasesorinfectionsthataﬀecthumanhealthdirectly.
Climate change may inﬂuence patterns of disease among
plants and animals, impacting the human food supply
(and thereby reducing human resistance to infections), or
indirectlycausinghumandiseasepatternstoshift,asthehost
range for disease reservoirs may change because of human
migration to geographically disparate areas and/or changes
in abundance and distribution of disease vectors and agents
[40–42].
In 2004, the World Health Organization (WHO) pub-
lished a study of the global disease burden attributable
to human-induced climate change up to the year 2000,
and made quantitative model-based predictions of climate
change-associated health risks up to 2030 [43]. Despite the
lack of comprehensive models for various speciﬁc climate-
disease relationships, overall results indicate that even the
subtle climatic changes occurring since the mid-1970s could
be responsible for over 150000 deaths from climate-sensitive
diseases, and approximately 5 million disability-adjusted
life years each year—the most vulnerable being the poorer
regions of the world, according to WHO estimates, although
climate change poses a global threat to public health
[43]. Diseases with which signiﬁcant association of climate
changes has already been observed include water- and food-
borne diseases (such as cryptosporidial diarrhea, salmonel-
losis, algal toxicity, and cholera), vector-borne diseases (such
as malaria, Chagas disease, borreliosis, schistosomiasis, and
dengue),rodent-bornediseases(suchasleptospirosis)aswell
as infections caused by the St. Louis Encephalitis virus and




respiratory ailments, cardiovascular diseases, neurological
and psychiatric disorders as well as those pertaining to
occupational health [44]. According to the WHO estimates
of morbidity and mortality associated with anthropogenic
climate change, the year 2030 would see a doubling of excess
risk of the various health outcomes [43].
5.C. gattii: Change of EnvironmentalNiche or
Adaptation to a New One
In Australia, in the early 1990s, Ellis and Pfeiﬀer observed a
correlation between the distributions of human cryptococcal
disease and of Eucalyptus trees [45, 46], whose bark is rich in4 Interdisciplinary Perspectives on Infectious Diseases
dihydroxyphenylalanine(L-DOPA),asubstancemetabolized
by Cryptococcus species to produce melanin; this has been
hypothesized to contribute to their environmental survival
[47, 48]. Association of C. gattii with Eucalyptus has been
sporadicallyreportedfromIndia,Brazil,Italy,andtheUnited
States [49–52]. However, the absence of this association with
Eucalyptus in other endemic areas, such as the Northern
Territory of Australia [53], Papua New Guinea [54], Central
and South Africa [55], Brazil, and Malaysia as well as
the isolation of C. gattii from non-Eucalyptus trees and
tree materials [56–60], indicates the existence of additional
environmental sources. Since it was ﬁrst discovered to have
a stable ecological niche on Vancouver Island in 2002, C.
gattii has consistently been recovered in high concentra-
tion from native trees, soil, air, freshwater, and seawater
[16, 19].
Does the Vancouver Island outbreak, then, point to
a changing ecological niche for this organism in Western
NorthAmerica? Fromthebeginning of the C.gattii epidemic
on Vancouver Island and adjoining areas, epidemiological
studies showed that all humans and animals with cryp-
tococcal infection either lived within or traveled to areas
identiﬁed by unique weather and vegetation zones. The
British Columbia Ministry of Forests categorizes areas with
similar ecologies within the province by biogeoclimatic zone
designations. A biogeoclimatic zone is a geographical area
with an ecosystem comprised of a relatively uniform macro-
climate, deﬁned vegetation, soils, and animal life inhabiting
that climate, and may contain smaller ecosystems (subzones)
t h a tr e ﬂ e c td i ﬀerences in regional climate, soil moisture, soil
nutrient status, and environmental disturbance [61]. The
unique zones along the eastern edge of Vancouver Island
are in the rain shadow of the Olympic Mountains located
in Washington State to the south, and include the Coastal
Douglas Fir (CDF) and very dry Coastal Western Hemlock
(CWH) biogeoclimatic zones. The CDF and very dry CWH
zones are characterized by warm, dry summers (average
summer temperature 15.6 ± 1.24◦C; 190.24 ± 55.5mm
rain), and mild, wet winters (average winter temperature
5.77 ± 0.64◦C; 884.33 ± 206.22mm rain). C. gattii has been
repeatedly and consistently isolated from the environment
in these biogeoclimatic zones [16, 19, 22]. The CDF and
CWH zones also include the Southern Gulf Islands and
portions of the BC Lower Mainland. Similar climates with
comparable temperature and rainfall extend further south
into Washington and Oregon in the United States. The
San Juan Islands, Puget Sound in Washington, and the
Willamette Valley in Oregon harbor ecologically similar
plant diversity as in BC, lending support to the idea that
environmental niches suitable for colonization by C. gattii,
are present in Western North America [16]. Indeed, large-
scale environmental sampling performed during 2001–2005
on the BC mainland, the Gulf Islands, and Washington
revealed that 3% of 2033 oﬀ-Vancouver Island samples of
air, water, soil, and trees were positive for C. gattii serotype B
( m o s t l yV G I I a ,e x c e p tt w oV G I s )[ 16].
Environmental sampling studies on Vancouver Island
revealedhighconcentrationsofC.gattiiinthesoil,indicating
a potential source of exposure [18], and data gathered from
the BC environment conclusively demonstrate that C. gattii
is well adapted for survival in a dry, nutrient-deprived
soil and is more likely to spread as airborne propagules
during dry summer weather [19]. However, whereas C.
gattii was consistently isolated from localized areas, it was
not found, or was below the limit of detection in other
areas, such as the San Juan Islands [62], despite ecological
similarity to identiﬁed zones of endemicity in Vancouver
Island and BC Lower Mainland. This suggests that there
may be environmental “hotspots”, that is, zones of high
concentration, of C. gattii within the same broad ecological
niches. There are also areas with transient colonization,
with sites intermittently positive over time, and some sites
which initially tested negative which subsequently either
became colonized, or the concentration rose above the limit
of detection [18, 19]. Whether microclimatic conditions
govern the creation and maintenance of these hotspots
is not known, but the fact remains that C. gattii now
inhabits a stable ecologic niche in the environment of the
Paciﬁc Northwest in concentrations high enough to pose
a risk of infection through environmental exposures. Prior
to the outbreak of C. gattii disease, there was no reason
to seek its presence in the environment, as there were no
cases of locally acquired infection, and C. gattii is not
a phytopathogen. The relationships between an emerging
pathogen and the environment are not often studied, and it
is even rarer that researchers have been able to document the
e m e r g e n c ew i t ha sm u c hd e t a i la sh a sb e e np o s s i b l ei nt h i s
BC outbreak. The unexpectedly rich dataset obtained from
BCenvironmentalandepidemiologicalecologiescanbeused
to inform future eco-health investigations. In this case, the
existence of libraries of cryptococcal strains from global
clinical and environmental origins provided the resources
for swift characterization and molecular epidemiology of
the causative organism; this information changed forever
the simplistic idea of unvarying geographic boundaries on
infectious organisms.
A promising tool which can be used by climatolo-
gists working with epidemiologists to predict public health
impacts is ecological niche modeling [63–65]. These com-
puter simulations take into account ecosystems, meteorol-
ogy, and the presence of pathogens in the environment
to predict areas with similar ecologies that may be at risk
of pathogen spread. A recently completed thesis from the
University of British Columbia using the Generic Algorithm
for Rule-set Prediction (GARP) modeled the potential for
C. gattii to spread to other areas of the Paciﬁc Northwest
[66]. Using existing data from human and animal clinical
cases and Geographic Information System (GIS) coordinates
of colonized environmental sites [18, 19, 21, 24], the model
predicts a larger area of potential colonization than is
currently the case. The predicted area includes cities with
large populations (over 4 million). Since this model was
developed, there have been at least four-human, eight-
animal, and four-environmental samples of C. gattii recov-
ered from the predicted zone which was not on Vancouver
Island [16, 17, 20]. By the same token, the vastly larger
land mass of British Columbia is predicted not to become
colonized with C. gattii in the foreseeable future due to theInterdisciplinary Perspectives on Infectious Diseases 5
extremes of temperature, snow cover, or lack of suitable
habitat [66].
C. gattii, similar to the congeneric pathogen C. neofor-
mans, has evolved mechanisms which protect it from the
environment. For example, the melanin production by these
organisms contributes to the protection from the ultraviolet
radiation in sunlight. The predominant genotype of the
Vancouver Island outbreak thrives in dry, nutrient poor soil
at high concentrations. It appears to be well adapted for
this marginal microecologic zone [19]. In Colombia, for
example, the dispersal of C. gattii is greater during periods of
high humidity or rain [67]. In Australia, the airborne distri-
bution of propagules is associated with the ﬂowering season
of Eucalyptus [68]. Neither of these conditions describes
the experience of the British Colombian genotypes VGIIa
or VGIIb, which suggests that the organism is successful
in this new ecologic niche because it can adapt preexisting
characteristicstoﬁllnovel,underutilizedmicroscopicniches,
rather than strictly requiring a constrained environment.
Even the widely held view that C. gattii was restricted to a
symbiotic relationship with Eucalyptus trees has since been
shown not to be the case, as C. gattii regularly colonizes
native trees in countries outside Australia [57, 58, 69].
Cyclical climate change patterns (called “oscillations”)
are driven by forces such as solar cycles and the ocean
currents characterized by the El Ni˜ no and La Ni˜ na years,
whereas more long-term changes, such as an elevation of
global temperatures, must be measured over decades or
centuries. Therefore, the problem of association of climate
changes with the epidemiology of various infectious diseases
is twofold. Climate changes may be long term, with the
potential to cause signiﬁcant epidemiological changes over
long-time horizons, or the climate may suddenly shift,
changing patterns and spread of exposure in a given climatic
zone. Both of these possibilities pose challenges to public
health studies.
That C. gattii emerged as a human and animal pathogen
in the late 1990s, in a new habitat, is indisputable. Whether
or not the climatic conditions (both short- and long-term)
in the new habitat made it conducive for the organism to do
so is under debate. The oscillatory climate change patterns
preceding the emergence were similar to the patterns seen
in this area over the last 30 years. The years 1992–1994 and
1998–2003 were dryer than the 30-year average during the
summer, followed by the years 1997, 2004, and 2005, which
had higher-than-average summer rainfall; the winter rains
roughly followed the same pattern. Importantly, however,
the amount of snow coverage on southern Vancouver Island
and the CDF biogeoclimatic zone decreased over the same
time period. This constantly repeating dry/wet pattern in
conjunction with the elevation of temperature may well be
a driving factor in the prolongation of C. gattii as a pathogen
in this geographic location. However, given the paucity of
long-term data on C. gattii emergence in relation to climate
changes, it is diﬃcult to attribute the emergence entirely to
climate change. A proof-of-concept example supporting the
notion is Coccidioides immitis, an environmental organism
which proliferates in wet years and is widely dispersed in
dry years, causing localized spikes in hospitalization for
areas adjacent to endemic locations [70]. For C. gattii,s o m e
factor(s) (climate, land use, human agency, etc.) must have
become permissive to the permanent colonization of the
organisminhighenoughconcentrationtocausediseasewith
an incidence rate of around 28 cases/million population (on
Vancouver Island alone) [16]. Identiﬁcation of those factors
would help formulate preventive public health approaches.
It is also clear that C. gattii disease has escalated to an
“oﬀ island” problem as well, involving the Northwestern US
(Washington and Oregon). The extent of disease and the
distribution of the cryptococcal isolates within the United
States are unknown, and will remain underappreciated until
laboratory methods to identify and speciate the isolates,
standardized reporting of disease, and environmental studies
are established.
C. gattii already had the ability to survive in a wide
range of environmental variations, but the Western North
America outbreak teaches us that it may exploit hitherto
unrecognizedbutclementenvironmentsandprovideawider
exposure, and thereby, risk of infection to the human and
animal populations. The challenge for public health is to
coordinate eﬀorts toward early recognition of the emergence
of new or reemergence of previously encountered infectious
diseases to alert primary health care providers as to the
diagnosis and appropriate treatment in order to prevent
excess morbidity and mortality. However, understanding the
consequences of ecological change is a group eﬀort which
includes health researchers, climatologists, and ultimately
global citizens whose health may depend on the capacity to
adapt to a rapidly changing environment.
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